Kinaxis Inc. (TSE:KXS – Get Free Report) insider Megan Paterson sold 983 shares of the company’s stock in a transaction dated Friday, August 14th. The shares were sold at an average price of C$171.46, for a total transaction of C$168,545.18. Following the sale, the insider owned 320 shares in the company, valued at C$54,867.20. This represents a 75.44% decrease in their ownership of the stock.
Kinaxis Stock Up 2.8%
Shares of TSE:KXS opened at C$177.15 on Thursday. The company has a current ratio of 1.88, a quick ratio of 2.29 and a debt-to-equity ratio of 11.14. Kinaxis Inc. has a 12 month low of C$117.22 and a 12 month high of C$196.63. The company has a 50-day moving average price of C$159.15 and a 200 day moving average price of C$146.48. The company has a market cap of C$4.82 billion, a price-to-earnings ratio of 57.89, a PEG ratio of 3.60 and a beta of 0.76.
Kinaxis (TSE:KXS – Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The company reported C$1.08 earnings per share for the quarter. Kinaxis had a return on equity of 20.88% and a net margin of 14.40%.The company had revenue of C$230.64 million for the quarter. As a group, equities research analysts predict that Kinaxis Inc. will post 4.2526231 earnings per share for the current year.
Wall Street Analyst Weigh In
Get Our Latest Stock Report on Kinaxis
Kinaxis Company Profile
Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain – from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption.
Featured Stories
- Five stocks we like better than Kinaxis
- One Platform, Every Ailment: Hinge Health’s Gamble
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.
